FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Methocarbamol Tablet, USP
Status: Discontinuation
»Therapeutic Categories: Analgesia/Addiction; Musculoskeletal

Endo Pharmaceuticals, Inc. (New 08/21/2019)

Company Contact Information:

Presentation Posting Date Related Information
Robaxin® 500mg, 100 Tablets (NDC 52244-429-10) 08/21/2019 Endo has made a business decision to permanently discontinue the drug product.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English